flow study semaglutide FLOWing with the — NephJC Semaglutide reduces cardiovascular events in

If the preclinical data are promising, the drug sponsor can apply for an Investigational New Drug (IND) application to initiate clinical trials in humans

A study in ( JAMA Ophthalmology (June 5, 2025) reported that people with type-2 diabetes using GLP-1 receptor agonists appear to have a higher risk of neovascular age-related macular degeneration (AMD) the wet form of the disease

In addition to losing 85 pounds, Dunham, who also suffers from PCOS, says her symptoms changed so much for the better that she wrote a book called The Girls Guide to Losing Weight on GLP-1 Medication

DHA levels increase in response to oxidative stress and are hypothesized to be associated with various ROS and protein glycation-related diseases, including senile cataracts (52)

We carried out an observation mission to the Retalhuleu and Champerico1 municipalities in March 2022, accompanying defenders from the Community Council of Retalhuleu (CCR) and the National Network for the Defense of Food Sovereignty of Guatemala (REDSAG)

Regulatory Track Record: History of FDA inspections, warning letters, and voluntary recalls